What is the current share price of MoneyMe Limited (MME)? MoneyMe Limited's (MME) current share price is $0.07. This constitutes a price movement of 1.45% when compared to the share price 7 days ago ...

What is the current share price of Bapcor Limited (BAP)? Bapcor Limited's (BAP) current share price is $0.80. This constitutes a price movement of 1.84% when compared to the share price 7 days ago and ...

What is the current share price of St George Mining Limited (SGQ)? St George Mining Limited's (SGQ) current share price is $0.07. This constitutes a price movement of 8.75% when compared to the share ...

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

What is the current share price of Halo Technologies Holdings Ltd (HAL)? Halo Technologies Holdings Ltd's (HAL) current share price is $0.01. This constitutes a price movement of 0% when compared to ...

What is the current share price of Clinuvel Pharmaceuticals Limited (CUV)? Clinuvel Pharmaceuticals Limited's (CUV) current share price is $8.15. This constitutes a price movement of 1.09% when ...

Insiders buying shares with their own money is usually a good sign. Unless, of course, you're Seek. Its latest result was bang average despite directors buying $4m worth of shares since February.

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Metrics Real Estate Multi-Strategy Fund (MRE). However, you won't necessarily see their names ...

IMPORTANT: This information is general financial product advice only and has not taken into account your objectives, financial situation or needs. Consider whether this advice is right for you. You ...

Contractors usually worry about running out of work. Southern Cross Electrical Engineering (SXE) and GenusPlus may soon have the opposite problem. Spending on data centres, electricity networks, ...

Investor neglect gave us a fleeting chance to buy the networks cheaply. That's now gone.

Hi, everyone, Stephen Mayne here. This week's CEO interview is with Jon Pilcher, the Chief Executive Officer and Managing Director of Neuren Pharmaceuticals Ltd, a very interesting New Zealand company ...